STOCK TITAN
  1. Home
  2. News
  3. RBOT

Vicarious Surgical Inc. - RBOT STOCK NEWS

Welcome to our dedicated news page for Vicarious Surgical (Ticker: RBOT), a resource for investors and traders seeking the latest updates and insights on Vicarious Surgical.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Vicarious Surgical's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Vicarious Surgical's position in the market.

News
Vicarious Surgical Announces New Hospital System Partnership with Intermountain Health
Rhea-AI Summary
Vicarious Surgical signs strategic development agreement with Intermountain Health, gaining access to their network and collaborating with experienced robotic surgeons. Partnership expected to provide patients with expanded minimally invasive treatment options and surgeons enhanced tools. Positive for stock price.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.65%
Tags
partnership
-
News
Vicarious Surgical to Present at the Gilmartin Group Emerging Growth Company Showcase
Rhea-AI Summary
Vicarious Surgical to present at Gilmartin Group Emerging Growth Company Showcase
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.72%
Tags
conferences acquisition
-
News
Vicarious Surgical to Present at the Canaccord Genuity 43rd Annual Growth Conference
Rhea-AI Summary
Vicarious Surgical Inc. will participate in the Canaccord Genuity 43rd Annual Growth Conference on August 9 at 2:30 p.m. ET. The company aims to improve patient outcomes and surgical procedure efficiency through robotics technology. A live webcast of the presentation will be available on the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.55%
Tags
conferences
News
Vicarious Surgical Announces Pricing of Public Offering
Rhea-AI Summary
Vicarious Surgical Inc. (RBOT) announced the pricing of its underwritten public offering of 45,000,000 shares of its Class A common stock at $1.00 per share, with an option to purchase up to an additional 6,750,000 shares. The Company expects to receive total gross proceeds of approximately $45.0 million from the offering.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-41.52%
Tags
offering
-
News
Vicarious Surgical Announces Launch of Proposed Public Offering
Rhea-AI Summary
Vicarious Surgical Inc. (RBOT) has announced a public offering of $45.0 million of its Class A common stock, with an option for underwriters to purchase up to $6.75 million of additional shares. The company intends to use the proceeds for ongoing operations and the development of its single-port surgical robot, the Vicarious Surgical System.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-41.52%
Tags
offering
-
News
Vicarious Surgical Reports Second Quarter 2023 Financial Results and Announces Clinical Plan and Regulatory Intent
Rhea-AI Summary
Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) announces Q2 2023 financial results, FDA clarity, and hospital system agreement. The company expects to complete the first ventral hernia procedure in a patient mid-2024. Operating expenses increased by 12% compared to the prior year. The company had $82.8 million in cash, cash equivalents, and short-term investments as of June 30, 2023, representing a quarterly cash burn of $14.9 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.75%
Tags
earnings
News
Vicarious Surgical to Report Second Quarter 2023 Financial Results on July 27, 2023
Rhea-AI Summary
Vicarious Surgical Inc. will report financial results for Q2 2023 on July 27, 2023. A conference call will be held at 4:30 p.m. ET. Webcast available at https://investor.vicarioussurgical.com.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.14%
Tags
conferences earnings
-
News
Vicarious Surgical Announces Promotion of John Mazzola to Chief Operating Officer
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.47%
Tags
management
-
News
Vicarious Surgical Reports First Quarter 2023 Financial Results
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.48%
Tags
earnings
News
Vicarious Surgical Earns Recognition from Fast Company and MedTech Breakthrough Awards
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.33%
Tags
none
Stock RBOT logo
Vicarious Surgical Inc.

NYSE:RBOT

RBOT Rankings

#4732 Ranked by Market Cap
#5472 Ranked by Stock Gains
N/A Ranked by Dividends

RBOT Stock Data

49.29M
96.94M
31.58%
42.72%
3.47%
Surgical Appliance and Supplies Manufacturing
Manufacturing
Link
United States of America
WALTHAM

About RBOT

at vicarious surgical we are revolutionizing the field of surgical robotics. we seek to improve the lives of patients, enhance the ability of surgeons, and expand worldwide access to high-quality care through the use of surgical robotics. we have reimagined what is possible by building a human-like surgical robot and combining it with the world’s first virtual-reality surgical camera to allow surgeons to perform minimally-invasive surgery with the ease of an open procedure.